Document Detail

Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants.
MedLine Citation:
PMID:  21975765     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Lactoferrin, a normal component of human colostrum, milk, tears and saliva can enhance host defence and may be effective in the prevention of sepsis and necrotizing enterocolitis (NEC) in preterm neonates.
OBJECTIVES: To assess the safety and effectiveness of oral lactoferrin in the prevention of sepsis and NEC in preterm neonates.
SEARCH STRATEGY: We used the search strategy of the Cochrane Neonatal Review Group (CNRG) including searches of CENTRAL (The Cochrane Library), MEDLINE and PREMEDLINE, EMBASE and CINAHL. We also searched trials registries and the conference proceedings of Pediatric Academic Society. Searches updated in July 2011.
SELECTION CRITERIA: Randomized or quasi-randomized controlled trials evaluating oral lactoferrin at any dose or duration for the prophylaxis of sepsis or NEC in preterm neonates.
DATA COLLECTION AND ANALYSIS: Data collection and analysis were performed according to the standard methods of the CNRG.
MAIN RESULTS: One trial (Manzoni 2008) that randomized 472 very low birth weight infants was eligible. A statistically significant reduction in late-onset sepsis was observed in the groups that received either lactoferrin alone (RR 0.34, 95% CI 0.17 to 0.70) or in combination with Lactobacillus rhamnosus GG (RR 0.27, 95% CI 0.12 to 0.60).In subgroup analyses, infants weighing less than 1000 g and those fed exclusively on maternal milk had a significant reduction in late-onset sepsis after oral lactoferrin supplementation alone. In the group supplemented with oral lactoferrin and Lactobacillus rhamnosus, infants weighing less than 1000 g had a significant reduction in late-onset sepsis, a result not seen in infants fed maternal milk exclusively.Prophylaxis with oral lactoferrin alone did not reduce the incidence of NEC (RR 0.33, 95% CI 0.09 to 1.17), but a significant reduction in NEC with a combination of lactoferrin and Lactobacillus rhamnosus GG was noted (RR 0.05, 95% CI 0.00 to 0.90).No adverse effects due to lactoferrin were observed in this study. Long-term neurological outcomes were not assessed in this trial.
AUTHORS' CONCLUSIONS: Oral lactoferrin prophylaxis reduces the incidence of late-onset sepsis in infants weighing less than 1500 g and most effective in infants weighing less than 1000 g. There is no evidence of efficacy of oral lactoferrin (given alone) in the prevention of NEC in preterm neonates.Well designed, randomized trials should address dosing, duration, type of lactoferrin (bovine or human) prophylaxis in prevention of sepsis and NEC. The effect of exclusive maternal milk feeding should be clarified.
Mohan Pammi; Steven A Abrams
Related Documents :
24463205 - Prebiotics and probiotics: the prevention and reduction in severity of atopic dermatiti...
11547505 - Ethical decision making in neonatal units--the normative significance of vitality.
25313945 - Infant mortality by birthweight and other characteristics: united states, 1985 birth co...
11958695 - Life-history correlates of the evolution of live bearing in fishes.
12140415 - Auditory erps reveal brain dysfunction in infants with plagiocephaly.
16925965 - Maternal blood aspiration: an unusual cause of respiratory distress in a neonate.
Publication Detail:
Type:  Journal Article; Review     Date:  2011-10-05
Journal Detail:
Title:  The Cochrane database of systematic reviews     Volume:  -     ISSN:  1469-493X     ISO Abbreviation:  Cochrane Database Syst Rev     Publication Date:  2011  
Date Detail:
Created Date:  2011-10-06     Completed Date:  2011-11-02     Revised Date:  2013-06-28    
Medline Journal Info:
Nlm Unique ID:  100909747     Medline TA:  Cochrane Database Syst Rev     Country:  England    
Other Details:
Languages:  eng     Pagination:  CD007137     Citation Subset:  IM    
Section of Neonatology, Department of Pediatrics, Baylor College of Medicine, 6621, Fannin, MC.WT 6-104, Houston, Texas, USA, 77030.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Enterocolitis, Necrotizing / prevention & control*
Infant, Newborn
Infant, Premature
Infant, Premature, Diseases / prevention & control*
Lactobacillus rhamnosus
Lactoferrin / administration & dosage*
Sepsis / prevention & control*
Reg. No./Substance:
EC 3.4.21.-/Lactoferrin
Update Of:
Cochrane Database Syst Rev. 2010;(5):CD007137   [PMID:  20464748 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Single dose intravenous propacetamol or intravenous paracetamol for postoperative pain.
Next Document:  Oral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates.